Cargando…
Predictors of response to viscosupplementation in patients with hip osteoarthritis: results of a prospective, observational, multicentre, open-label, pilot study
BACKGROUND: To identify predictive factors of response to viscosupplementation (VS) in patients with hip osteoarthritis (HOA). METHODS: Prospective, multicentre, open-label trial, achieved in daily practice conditions. Patients with HOA were treated with a single intra-articular injection of a cross...
Autores principales: | Eymard, Florent, Maillet, Bernard, Lellouche, Henri, Mellac-Ducamp, Sylvie, Brocq, Olivier, Loeuille, Damien, Chevalier, Xavier, Conrozier, Thierry |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5217257/ https://www.ncbi.nlm.nih.gov/pubmed/28056915 http://dx.doi.org/10.1186/s12891-016-1359-2 |
Ejemplares similares
-
Impact of obesity, structural severity and their combination on the efficacy of viscosupplementation in patients with knee osteoarthritis
por: Conrozier, Thierry, et al.
Publicado: (2019) -
Safety and Predictive Factors of Short-Term Efficacy of a Single Injection of Mannitol-Modified Cross-Linked Hyaluronic Acid in Patients with Trapeziometacarpal Osteoarthritis. Results of a Multicentre Prospective Open-Label Pilot Study (INSTINCT Trial)
por: Dauvissat, Jérémy, et al.
Publicado: (2018) -
Viscosupplementation for the treatment of osteoarthritis. The contribution of EUROVISCO group
por: Conrozier, Thierry, et al.
Publicado: (2021) -
EUROVISCO Good Practice Recommendations for a First Viscosupplementation in Patients with Knee Osteoarthritis
por: Conrozier, Thierry, et al.
Publicado: (2022) -
When is indicated viscosupplementation in hip osteoarthritis?
por: Francesco, Pogliacomi, et al.
Publicado: (2019)